Literature DB >> 2190375

Pharmacokinetics of cyclosporine: inter- and intra-individual variations and metabolic pathways.

M Lemaire1, A Fahr, G Maurer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2190375

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

Review 1.  Immunosuppressive drugs in renal transplantation. A review of the regimens.

Authors:  J M Barry
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

2.  Low-density lipoproteins enhance transforming growth factor-beta 1 (TGF-beta 1) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells.

Authors:  S Di Paolo; G Grandaliano; L Gesualdo; E Ranieri; F P Schena
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

3.  Gene expression of cytochromes P450 in liver transplants over time.

Authors:  Mari Thörn; Stefan Lundgren; Gustaf Herlenius; Bo-Göran Ericzon; Lars Lööf; Anders Rane
Journal:  Eur J Clin Pharmacol       Date:  2004-06-10       Impact factor: 2.953

Review 4.  Acute cyclosporin overdose. A review of present clinical experience.

Authors:  F Arellano; C Monka; P F Krupp
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

5.  Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.

Authors:  Yu-Yuan Chiu; Kazutaka Higaki; Brien L Neudeck; Jeffrey L Barnett; Lynda S Welage; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

6.  Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study.

Authors:  R García del Moral; F O'Valle; M Andújar; M Aguilar; M A Lucena; J López-Hidalgo; C Ramírez; M T Medina-Cano; D Aguilar; M Gómez-Morales
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

7.  Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis.

Authors:  B E van den Borne; R B Landewé; H S Goei The; H Mattie; F C Breedveld; B A Dijkmans
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.